Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 528

1.

Bone and Calcified Soft Tissue Metastases of Medullary Thyroid Carcinoma Better Characterized on 18F-Fluoride PET/CT than on 68Ga-Dotatate PET/CT.

Duarte PS, de Castroneves LA, Sado HN, Sapienza MT, de Oliveira Hoff AAF, Buchpiguel CA.

Nucl Med Mol Imaging. 2018 Aug;52(4):318-323. doi: 10.1007/s13139-018-0527-8. Epub 2018 Jun 4.

PMID:
30100945
2.

Prevalence and Risk Factors of Atypical Femoral Fracture Bone Scintigraphic Feature in Patients Experiencing Bisphosphonate-Related Osteonecrosis of the Jaw.

Lee CH, Son SH, Hong CM, Jeong JH, Jeong SY, Lee SW, Lee J, Kwon TG, Ahn BC.

Nucl Med Mol Imaging. 2018 Aug;52(4):311-317. doi: 10.1007/s13139-018-0533-x. Epub 2018 Jul 16.

PMID:
30100944
3.

Capabilities of the Monte Carlo Simulation Codes for Modeling of a Small Animal SPECT Camera.

Sadremomtaz A, Telikani Z.

Nucl Med Mol Imaging. 2018 Aug;52(4):303-310. doi: 10.1007/s13139-018-0530-0. Epub 2018 Jun 21.

PMID:
30100943
4.

A Comparison of the Accuracy of Different Single Plasma Sample Methods for Measuring Glomerular Filtration Rate Using 51Cr-EDTA in Children.

Ha S, Lee JJ.

Nucl Med Mol Imaging. 2018 Aug;52(4):293-302. doi: 10.1007/s13139-018-0529-6. Epub 2018 Jun 28.

PMID:
30100942
5.

Response Prediction of Altered Thyroglobulin Levels After Radioactive Iodine Therapy Aided by Recombinant Human Thyrotropin in Patients with Differentiated Thyroid Cancer.

Song M, Jeon S, Kang SR, Jabin Z, Yoo SW, Min JJ, Bom HS, Cho SG, Kim J, Song HC, Kwon SY.

Nucl Med Mol Imaging. 2018 Aug;52(4):287-292. doi: 10.1007/s13139-018-0528-7. Epub 2018 Jun 4.

PMID:
30100941
6.

Measurement of 68Ga-DOTATOC Uptake in the Thoracic Aorta and Its Correlation with Cardiovascular Risk.

Lee R, Kim J, Paeng JC, Byun JW, Cheon GJ, Lee DS, Chung JK, Kang KW.

Nucl Med Mol Imaging. 2018 Aug;52(4):279-286. doi: 10.1007/s13139-018-0524-y. Epub 2018 May 22.

PMID:
30100940
7.

Emerging Tracers for Nuclear Cardiac PET Imaging.

Kim DY, Cho SG, Bom HS.

Nucl Med Mol Imaging. 2018 Aug;52(4):266-278. doi: 10.1007/s13139-018-0521-1. Epub 2018 May 8. Review.

PMID:
30100939
8.

Current Consensus on I-131 MIBG Therapy.

Kayano D, Kinuya S.

Nucl Med Mol Imaging. 2018 Aug;52(4):254-265. doi: 10.1007/s13139-018-0523-z. Epub 2018 May 3. Review.

PMID:
30100938
9.

Factors Associated with Dose Determination of Radioactive Iodine Therapy for Differentiated Thyroid Cancer.

Hong CM, Ahn BC.

Nucl Med Mol Imaging. 2018 Aug;52(4):247-253. doi: 10.1007/s13139-018-0522-0. Epub 2018 May 2. Review.

PMID:
30100937
10.

Incidental Detection of Peri-Renal Hemorrhage on F-18 FDG PET/CT Imaging in a Patient with Polycystic Kidney Disease.

Kim MH, Kim DW.

Nucl Med Mol Imaging. 2018 Jun;52(3):243-246. doi: 10.1007/s13139-018-0513-1. Epub 2018 Feb 1.

PMID:
29942405
11.

Incidental Detection of Parathyroid Adenoma on Somatostatin Receptor PET/CT and Incremental RoleĀ of 18F-Fluorocholine PET/CT in MEN1 Syndrome.

Arora S, Damle NA, Passah A, Yadav MP, Ballal S, Aggarwal V, Gupta Y, Kumar P, Tripathi M, Bal C.

Nucl Med Mol Imaging. 2018 Jun;52(3):238-242. doi: 10.1007/s13139-018-0520-2. Epub 2018 May 2.

PMID:
29942404
12.

Survey Result of the Counting Efficiency of Gamma Counter by Certified Reference Materials.

Bang JI, Lee HY, Noh GW, Park JM, Yoon JK.

Nucl Med Mol Imaging. 2018 Jun;52(3):234-237. doi: 10.1007/s13139-018-0515-z. Epub 2018 Mar 14.

PMID:
29942403
13.

Analysis of Iodine Content in Salts and Korean Sauces for Low-Iodine Diet Education in Korean Patients with Thyroid Cancer Preparing for Radioiodine Therapy.

Kim SY, Park JM, Hwang JP.

Nucl Med Mol Imaging. 2018 Jun;52(3):229-233. doi: 10.1007/s13139-017-0511-8. Epub 2018 Feb 5.

PMID:
29942402
14.

A Single Intraperitoneal Injection of Endotoxin Changes Glial Cells in Rats as Revealed by Positron Emission Tomography Using [11C]PK11195.

Ota M, Ogura J, Ogawa S, Kato K, Matsuda H, Kunugi H.

Nucl Med Mol Imaging. 2018 Jun;52(3):224-228. doi: 10.1007/s13139-017-0510-9. Epub 2018 Jan 8.

PMID:
29942401
15.

Evaluating the Predictive Ability of Initial Staging F-18 FDG PET/CT for the Prognosis of Non-Hodgkin Malignant Lymphoma Patients Who Underwent Stem Cell Transplantation.

Park YS, Lee SM, Park JS, Bae SK, Shim HK, Lee WS, Lee SM.

Nucl Med Mol Imaging. 2018 Jun;52(3):216-223. doi: 10.1007/s13139-017-0503-8. Epub 2017 Nov 21.

PMID:
29942400
16.

Lu-177-Based Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors.

Kim K, Kim SJ.

Nucl Med Mol Imaging. 2018 Jun;52(3):208-215. doi: 10.1007/s13139-017-0505-6. Epub 2017 Nov 20. Review.

PMID:
29942399
17.

Treatment of Bone Metastasis with Bone-Targeting Radiopharmaceuticals.

Choi JY.

Nucl Med Mol Imaging. 2018 Jun;52(3):200-207. doi: 10.1007/s13139-017-0509-2. Epub 2018 Jan 12. Review.

PMID:
29942398
18.

Peptide Receptor Radionuclide Therapy and the Treatment of Gastroentero-pancreatic Neuroendocrine Tumors: Current Findings and Future Perspectives.

Hirmas N, Jadaan R, Al-Ibraheem A.

Nucl Med Mol Imaging. 2018 Jun;52(3):190-199. doi: 10.1007/s13139-018-0517-x. Epub 2018 Mar 28. Review.

PMID:
29942397
19.

Radiomics in Oncological PET/CT: Clinical Applications.

Lee JW, Lee SM.

Nucl Med Mol Imaging. 2018 Jun;52(3):170-189. doi: 10.1007/s13139-017-0500-y. Epub 2017 Oct 20. Review.

PMID:
29942396
20.

Contribution of Radionuclide Theranostics for Managing Intractable Malignancies.

Ahn BC.

Nucl Med Mol Imaging. 2018 Jun;52(3):168-169. doi: 10.1007/s13139-018-0526-9. Epub 2018 May 24. No abstract available.

PMID:
29942395

Supplemental Content

Loading ...
Support Center